Catherine has over 20 years’ experience in clinical research with a focus on complex and early phase oncology trials, including oncolytic viruses. Prior to joining the newly founded Turnstone Biologics, in 2016, Catherine acquired invaluable experience on the site side of clinical research, including program management and serving as a reviewer for an oncology based ethics board for 5 years. In her new role as Clinical Site Education Manager at Turnstone Biologics, Catherine draws upon all of this experience to provide a unique level of support to sites.
